Robert Jacobi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert Jacobi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Frances M. Ashcroft
Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK
1 shared publication - Jens Eilers
Carl Ludwig Institute for Physiology, Medical Faculty, Leipzig University, Leipzig, Germany
1 shared publication - Jorge Vera
Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine , Bronx, NY 10461
1 shared publication - Josephine Kurzke
Carl-Ludwig-Institute for Physiology, Faculty of Medicine, Leipzig University , Leipzig 04103
1 shared publication - Kristina Lippmann
Carl-Ludwig-Institute of Physiology, Faculty of Medicine, Leipzig University, Leipzig 04103, Germany
1 shared publication - Marie-Elisabeth Burkart
Carl-Ludwig-Institute for Physiology, Faculty of Medicine, Leipzig University , Leipzig 04103
1 shared publication
Latest Publications
- 15 May 2024
- Published by Oxford University Press (OUP) in Brain
- Vol. 147 (12) , 4200-4212
KATP channel mutation disrupts hippocampal network activity and nocturnal gamma shifts
ATP-sensitive potassium (KATP) channels couple cell metabolism to cellular electrical activity. Humans affected by severe activating mutations in KATP channels suffer from developmental delay, epilepsy, and neonatal diabetes (DEND syndrome). While the aetiology of diabetes in DEND syndrome is well understood, the pathophysiology of the neurological symptoms remains unclear. We hypothesised that impaired activity of parvalbumin-positive interneurons (PV-INs) may result in seizures and cognitive problems. We found, by performing electrophysiological experiments, that expressing the DEND mutation Kir6.2-V59M selectively in mouse PV-INs reduced intrinsic gamma frequency preference and short-term depression as well as disturbed cognition-associated gamma oscillations and hippocampal sharp waves. Furthermore, the risk of seizures was increased and the day-night shift in gamma activity disrupted. Blocking KATP channels with tolbutamide partially rescued the network oscillations. The non-reversible part may, to some extent, result from observed altered PV-IN dendritic branching and PV-IN arrangement within CA1. In summary, PV-INs play a key role in DEND syndrome, and this provides a framework for establishing treatment options.
- 15 May 2024
- Published by Oxford University Press (OUP) in Brain
- Vol. 147 (12) , 4200-4212
KATP channel mutation disrupts hippocampal network activity and nocturnal gamma shifts
ATP-sensitive potassium (KATP) channels couple cell metabolism to cellular electrical activity. Humans affected by severe activating mutations in KATP channels suffer from developmental delay, epilepsy, and neonatal diabetes (DEND syndrome). While the aetiology of diabetes in DEND syndrome is well understood, the pathophysiology of the neurological symptoms remains unclear. We hypothesised that impaired activity of parvalbumin-positive interneurons (PV-INs) may result in seizures and cognitive problems. We found, by performing electrophysiological experiments, that expressing the DEND mutation Kir6.2-V59M selectively in mouse PV-INs reduced intrinsic gamma frequency preference and short-term depression as well as disturbed cognition-associated gamma oscillations and hippocampal sharp waves. Furthermore, the risk of seizures was increased and the day-night shift in gamma activity disrupted. Blocking KATP channels with tolbutamide partially rescued the network oscillations. The non-reversible part may, to some extent, result from observed altered PV-IN dendritic branching and PV-IN arrangement within CA1. In summary, PV-INs play a key role in DEND syndrome, and this provides a framework for establishing treatment options.